| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.078 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |